Antibody-drug Conjugates (ADC)

Allyl (2-aminoethyl)carbamate hydrochloride serves as a cleavable linker in antibody-drug conjugates (ADCs). It facilitates the release of therapeutic agents in targeted cancer therapies, enhancing the specificity and efficacy of treatment. This compound is valuable for research applications focusing on ADC development and optimization.

Cyclooctyne-O-PFP ester is a cleavable linker designed for use in antibody-drug conjugates (ADCs). This reagent features an alkyne functional group, facilitating copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules. Its efficient coupling and release properties enhance the development of targeted therapeutics in medicinal chemistry and drug delivery applications.

Allyl (2-aminoethyl)carbamate is a cleavable linker designed for use in antibody-drug conjugate (ADC) development. This compound facilitates the attachment of cytotoxic agents to targeting antibodies, enabling selective delivery to cancer cells. Its stability under physiological conditions and subsequent release mechanism make it a valuable tool in enhancing the therapeutic efficacy of ADCs in cancer research.

Azido-PEG4-Val-Cit-PAB-OH is a cleavable polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs) and proteolysis-targeting chimeras (PROTACs). This compound features an azide group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules, as well as strain-promoted alkyne-azide cycloaddition (SPAAC) with DBCO or BCN moieties. Its versatility as a click chemistry reagent supports diverse applications in chemical biology and drug development.

m-PEG11-acid is a non-cleavable linker composed of 11 ethylene glycol units, functioning as a versatile agent in the synthesis of antibody-drug conjugates (ADCs) and PROTACs. This polyethylene glycol (PEG)-based linker enhances the solubility and pharmacokinetics of the conjugates while facilitating targeted degradation of proteins in research applications. m-PEG11-acid is crucial for investigating the mechanisms of protein regulation and therapeutic strategies in drug discovery.

PDP-Pfp is a reducible ADC linker designed to enable targeted delivery of antibody-drug conjugates (ADCs) to the extracellular loop 1 (ECL1) of TM4SF1 (transmembrane 4 L6 family member 1). This linker facilitates effective payload release in the tumor microenvironment, enhancing the therapeutic potential of ADCs. It is suitable for applications in cancer research and the development of innovative therapeutics targeting TM4SF1-related pathways.

D-Proline, 4-hydroxy-, methyl ester hydrochloride is a non-cleavable linker specifically designed for antibody-drug conjugates (ADCs). This compound serves as a key component in the synthesis of ADCs, facilitating the stable attachment of therapeutic agents to antibodies. Additionally, it functions as an alkyl chain-based PROTAC linker, enabling the development of proteolysis-targeting chimeras for targeted protein degradation research.

vc-PABC-DM1 is an antibody-drug conjugate (ADC) linker that incorporates a disulfide bond to facilitate controlled drug release. This compound is instrumental in synthesizing ADCs, allowing for targeted delivery of toxins to cancer cells. Additionally, vc-PABC-DM1 can be utilized in studies assessing serum stability, contributing to the understanding of ADC pharmacokinetics and therapeutic efficacy.

SPDMB is a glutathione-cleavable linker designed for antibody-drug conjugates (ADCs). This compound enables the selective release of cytotoxic agents within target cells, enhancing therapeutic efficacy while minimizing systemic toxicity. SPDMB is crucial for constructing ADCs in research applications focused on targeted cancer therapies and drug delivery mechanisms.

bis-PEG2-endo-BCN is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a cyclooctyne (BCN) moiety that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling precise conjugation. Its implementation in ADC development enhances targeted delivery of therapeutics, making it valuable for research applications in oncology and drug development.

Azidoethyl-SS-ethylazide is a cleavable linker specifically designed for antibody-drug conjugate (ADC) synthesis. This compound features an azide moiety allowing it to participate in copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-functionalized molecules. Additionally, Azidoethyl-SS-ethylazide can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with entities containing dibenzocyclooctyne (DBCO) or bicyclo[6.1.0]non-4-yne (BCN) groups, facilitating efficient conjugation in chemical biology applications.

Sulfo-SNPB is a cleavable linker designed for use in antibody-drug conjugates (ADCs). It facilitates the conjugation of antibodies to therapeutic agents, allowing for targeted delivery and enhanced efficacy in cancer treatment. This linker is ideal for research applications focused on developing innovative ADC formulations and optimizing drug delivery systems.

Mal-Ph-CONH-PEG4-NHS ester is a non-cleavable linker designed for use in antibody-drug conjugates (ADCs). This 4-unit polyethylene glycol (PEG) linker facilitates the stable attachment of cytotoxic agents to antibodies, enhancing the efficacy and specificity of targeted therapies. It is suitable for research applications aimed at developing advanced ADC formulations for cancer treatment.

Folate-PEG3-amine is a cleavable 3-unit polyethylene glycol (PEG) linker designed for the synthesis of antibody-drug conjugates (ADCs). The folate moiety facilitates targeted delivery to folate receptor-expressing cells, enhancing therapeutic efficacy while minimizing off-target effects. This reagent is ideal for research applications focused on the development and optimization of ADCs for cancer treatment.

Ald-Ph-amido-PEG2-C2-NHS ester is a non-cleavable linker designed for antibody-drug conjugation (ADC) applications. This 2-unit PEG linker facilitates stable attachment between antibodies and various cytotoxic agents, enhancing the therapeutic potential of ADCs. Its robust structure promotes efficient delivery and release of therapeutic agents, making it suitable for cancer research and targeted therapy development.

Hydroxy-PEG1-acid is a non-cleavable polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs). This reagent facilitates the conjugation of therapeutic antibodies to cytotoxic drugs, enhancing their efficacy and selectivity against target cells. Its properties make it an ideal choice for optimizing ADC formulation and improving pharmacokinetics in cancer therapeutics and other targeted therapies.

m-PEG4-MS is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTACs and antibody-drug conjugates (ADCs). This cleavable linker facilitates the precise delivery of therapeutic agents, enhancing the stability and efficacy of the resulting compounds. Its application in PROTAC development and ADC formulation supports research into targeted protein degradation and innovative cancer therapies.

INX-P is an antibody-drug conjugate (ADC) linker designed for targeting glucocorticosteroids. It facilitates the delivery of cytotoxic agents specifically to cancer cells that express glucocorticoid receptors, enhancing therapeutic efficacy while minimizing systemic toxicity. This linker is particularly useful in research applications focusing on ADC development and targeted cancer therapies.

Gly-NH-CH2-Boc is a cleavable linker utilized in the synthesis of antibody-drug conjugates (ADCs). This reagent facilitates the attachment of cytotoxic agents to antibodies, allowing for targeted delivery of therapeutic compounds to cancer cells while minimizing off-target effects. Its application is critical in the development of novel ADCs for improved treatment efficacy in oncology research.

m-PEG7-Amine is a polyethylene glycol (PEG)-based linker designed for use in PROTAC (Proteolysis Targeting Chimeras) and antibody-drug conjugate (ADC) synthesis. This cleavable linker facilitates the targeted degradation of specific proteins, enhancing the efficacy of PROTACs. Its versatile application makes it an essential component in developing therapeutic modalities aimed at selective protein modulation and cancer treatment.

Boc-Val-Dil-Dap-OH is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates targeted drug delivery by enabling the release of cytotoxic agents selectively within tumor cells. Its unique structural features enhance the stability and efficacy of ADCs, making it suitable for research applications focused on cancer therapeutics and drug development.

Mal-PEG3-C1-NHS ester is a non-cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This triethylene glycol-based compound facilitates effective conjugation by providing a stable connection between the antibody and the therapeutic payload. Its application is crucial in enhancing the therapeutic efficacy and selectivity of ADCs in targeted cancer therapies and drug delivery systems.

Me-triacetyl-β-D-glucopyranuronate-Ph-ald-NO2 is a cleavable linker specifically designed for the construction of antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic agents upon internalization by target cells, enhancing the therapeutic efficacy and reducing off-target effects. Its application in ADC development supports the advancement of targeted cancer therapies and other biopharmaceutical innovations.

Ald-CH2-PEG3-azide is a cleavable polyethylene glycol (PEG)-based linker designed for use in antibody-drug conjugates (ADCs) and proteolysis-targeting chimera (PROTAC) synthesis. This compound features an azide group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) and strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with alkyne-bearing molecules or DBCO/BCN groups. Its versatile chemistry facilitates the development of ADCs and PROTACs, making it invaluable for drug delivery and targeted therapeutic applications in chemical research.

Ald-Ph-amido-PEG4-C2-acid is a non-cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). Its chemical structure facilitates stable attachment of drug molecules to antibodies, enhancing the therapeutic efficacy of ADCs. This linker is crucial for applications in targeted cancer therapy, allowing for the selective delivery of cytotoxic agents to tumors while minimizing off-target effects.

MC-VC-PAB-NH2 is a cleavable linker designed for the efficient synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic agents upon internalization by target cells, enhancing the therapeutic efficacy of ADCs. MC-VC-PAB-NH2 is ideal for researchers developing targeted cancer therapies, allowing for controlled drug delivery and reduced off-target effects.

Mal-PEG2-Val-Cit-PABA is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the selective release of cytotoxic agents within target cells, enhancing therapeutic efficacy while minimizing off-target effects. Its structure promotes stability during circulation and triggers cleavage in the presence of specific intracellular conditions, making it a valuable tool for ADC development and research applications in cancer treatment.

m-PEG10-alcohol is a non-cleavable linker comprised of a decaethylene glycol unit, primarily used in the design of antibody-drug conjugates (ADCs). This PEG-based compound serves as a versatile PROTAC linker, facilitating the development of proteolysis-targeting chimeras. Its structure enhances solubility and stability, making it suitable for various chemical biology applications, including targeted protein degradation studies.

NHPI-PEG4-C2-NHS ester is a versatile ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound serves as a critical bifunctional reagent, facilitating the stable attachment of therapeutic agents to antibodies. Its characteristics support the effective delivery of cytotoxic drugs, enhancing the specificity and efficacy of targeted cancer therapies. Research applications include the development and optimization of ADCs for improved therapeutic outcomes in oncology.

Fmoc-Gly3-Val-Cit-PAB is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the release of cytotoxic agents upon lysosomal cleavage, thereby enhancing the efficacy of targeted cancer therapies. It is utilized in the development of ADCs to improve specificity and reduce systemic toxicity in various oncological research applications.

Fmoc-Lys(DOTA)-OH is a versatile linker for antibody-drug conjugates (ADCs) that facilitates the conjugation of therapeutic agents to antibodies. Its DOTA moiety allows for stable coordination with various metal ions, enhancing the delivery of cytotoxic drugs to specific cells. This compound is instrumental in the development of targeted cancer therapies and other applications in drug delivery systems.

Fmoc-Val-D-Cit-PAB is a cleavable linker designed for antibody-drug conjugation (ADC) applications. This compound facilitates the selective release of cytotoxic agents in targeted therapies, enhancing the efficacy of treatments while minimizing off-target effects. Fmoc-Val-D-Cit-PAB is suitable for use in various research contexts, particularly in the development of novel ADCs for cancer therapy.

Mal-PEG4-Val-Cit-PAB-OH is a cleavable polyethylene glycol (PEG) linker designed for the synthesis of antibody-drug conjugates (ADCs). This linker features a Val-Cit dipeptide sequence that permits selective release of the cytotoxic drug upon cellular uptake. Its application enhances the therapeutic index of ADCs by improving solubility and stability while facilitating effective drug delivery in targeted cancer therapies.

Sulfo-LC-SPDP is a heterobifunctional crosslinker designed for antibody-drug conjugate (ADC) applications. It features a thiol-cleavable moiety that facilitates selective release of the drug component upon exposure to free thiol groups. Its membrane impermeability ensures that the linker remains within the cellular compartments, making it suitable for targeted delivery of therapeutics. This compound is widely utilized in research focusing on ADC development, enabling improved efficacy and specificity in cancer therapy.

(2R,4R)-4-Hydroxypyrrolidine-2-carboxylic acid hydrochloride functions as a non-cleavable linker in the development of antibody-drug conjugates (ADCs). Furthermore, it serves as an alkyl chain-based PROTAC linker, facilitating the synthesis of PROTACs. This compound plays a crucial role in advancing targeted protein degradation research, contributing to the exploration of innovative therapeutic strategies.

Mal-amido-(CH2COOH)2 is a maleimidoethyl-containing intermediate designed for use as a hydrophilic linker in antibody-drug conjugates (ADCs). This compound facilitates the stable attachment of cytotoxic agents to antibodies, enhancing the therapeutic efficacy while minimizing off-target effects. Its application in ADC development supports research aimed at precision medicine and targeted cancer therapies.

PEG4-SPDP is a cleavable linker specifically designed for use in antibody-drug conjugates (ADCs). It facilitates the stable attachment of cytotoxic agents to antibodies, allowing for targeted delivery and selective cytotoxicity. This reagent is essential for research applications in cancer therapeutics, enabling the development of innovative treatments through the precise modulation of targeted drug release in tumor environments.

Amino-Tri-(carboxyethoxymethyl)-methane hydrochloride is a cleavable PEG linker specifically designed for use in the synthesis of antibody-drug conjugates (ADCs). Its structural properties facilitate efficient conjugation, enhancing the therapeutic efficacy of ADCs. Additionally, this compound serves as a PEG-based PROTAC linker, enabling targeted protein degradation applications in research. Its versatile applications make it an essential reagent for advancing drug development and therapeutic strategies.

DBCO-NHS Ester 3 is a cleavable linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound features a dibenzocyclooctyne (DBCO) moiety that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules, enabling efficient conjugation. DBCO-NHS Ester 3 is utilized in various applications involving targeted drug delivery and bioconjugation strategies in chemical biology and therapeutic development.

SCO-PEG3-NH2 is a cleavable antibody-drug conjugate (ADC) linker designed for effective drug delivery. This linker consists of three polyethylene glycol (PEG) units, facilitating enhanced solubility and stability. SCO-PEG3-NH2 serves as a copper-free click chemistry reagent, enabling catalyst-free conjugation in bioconjugation applications. It is suitable for research focused on the development of targeted therapeutics and bioconjugate systems.

Mal-PEG2-VCP-NB is a cleavable antibody-drug conjugate (ADC) linker featuring a Maleimide group, a polyethylene glycol (PEG) spacer of two units, and a valine-citrulline-p-nitrobenzyl (VCP-NB) moiety. This linker is designed to improve the delivery of cytotoxic agents specifically to target cells while minimizing off-target effects. Its application in ADC development supports research aimed at enhancing therapeutic efficacy in cancer treatment and advancing targeted drug delivery systems.

MC-Gly-Gly-{D-Phe}-Gly-NH-CH2-O-CH2COOH is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). This compound facilitates the targeted delivery of cytotoxic agents, enhancing therapeutic efficacy while minimizing off-target effects. Its specific cleavage mechanism allows for the release of the drug inside the target cells, making it a valuable tool for cancer research and therapeutic development in precision medicine.

Bis-SS-C3-NHS ester is a cleavable linker designed for use in the synthesis of antibody-drug conjugates (ADCs). It facilitates the covalent attachment of cytotoxic agents to antibodies, ensuring selective delivery to target cells. This linker is particularly valuable for enhancing the therapeutic efficacy of ADCs in cancer research and targeting specific tumor types, allowing for controlled release of active drugs upon internalization.

Cis-4-Hydroxy-L-proline hydrochloride is a cleavable ADC linker designed for the synthesis of antibody-drug conjugates (ADCs). This compound serves as a versatile tool in targeted drug delivery, enhancing the therapeutic efficacy of ADCs. Additionally, it functions as a PEG-based PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs) for targeted protein degradation studies.

SCO-PEG2-NH2 is a cleavable ADC linker featuring two PEG units, designed to facilitate the delivery of cytotoxic agents in antibody-drug conjugates (ADCs). This linker serves as a copper-free click chemical reagent, enabling efficient catalyst-free click reactions. It is beneficial for researchers engaging in the development and optimization of ADCs, enhancing their therapeutic potential in targeted cancer treatment.

Gly-Gly-Gly-PEG4-methyltetrazine is a cleavable polyethylene glycol (PEG) linker designed for use in antibody-drug conjugates (ADCs). It features a tetrazine moiety that facilitates rapid and selective conjugation through an inverse electron demand Diels-Alder (iEDDA) reaction with trans-cyclooctene (TCO) derivatives. This compound enhances the stability and efficacy of ADCs, making it valuable for targeted delivery of therapeutics in cancer research and other applications in bioconjugation.

Me-Tet-PEG8-Maleimide is an ADC linker featuring eight polyethylene glycol (PEG) units, designed for applications in antibody-drug conjugate (ADC) development. It incorporates a Tetrazine group capable of engaging in a specific inverse electron demand Diels-Alder (iEDDA) reaction with trans-cyclooctene (TCO) compounds, facilitating targeted drug delivery. Additionally, the maleimide functionality exhibits stability in aqueous conditions, making it suitable for various bioconjugation studies and enhancing drug solubility and circulation time.

MC-GGFG-NH-CH2-O-CH2-(s-cyclopropane)-COOH is an antibody-drug conjugate (ADC) linker designed for effective drug-targeting applications. This compound forms a drug-linker conjugate with the cytotoxic agent Camptothecin, enhancing its delivery and selectivity. When conjugated to the antibody Trastuzumab, it facilitates the formation of highly specific ADCs, making it a valuable tool for targeted cancer therapy research.

Aminooxy-amido-PEG4-propargyl is a non-cleavable linker designed for use in antibody-drug conjugates (ADCs). This versatile linker features an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. Its application in ADC synthesis enhances targeted delivery and efficacy of therapeutic agents, making it a valuable tool in cancer research and drug development.

Sulfo-SPP is a heterobifunctional crosslinker characterized by its thiol-cleavable nature and membrane impermeability. This reagent is designed for use in antibody-drug conjugate (ADC) applications, enabling the selective modification of biomolecules. Its unique properties facilitate the construction of stable conjugates while allowing for controlled release of therapeutic agents in target cells, making it a valuable tool in chemical biology and drug development research.